Transaction · 0002154030-26-000007

Vogelstein R Jacob

Vogelstein R Jacob, DIR, reported a transaction classified as unknown at Iambic Therapeutics, Inc. involving 742546.000000 shares for an estimated $0.00. Reported holdings after the transaction were 0.000000 shares. A 10b5-1 reference was not detected in the stored filing text.

unknownSEC transaction code CDIR
IAMIambic Therapeutics, Inc.
Trade date
Oct 16, 2026
Filing date
Oct 19, 2026
View on SEC Insider profile
Estimated value$0Shares × reported price
Shares traded742k$0.00 per share
Holdings after0Indirect · See footnote
% of reported position tradedUnavailableThis security and ownership context
How reported position traded is calculated

Not calculated for derivative securities.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

IAM price since this filing

Daily closing prices, with the filing date and available return windows
IAM · Daily closing priceLoading daily prices…
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d30d90d180d1y

Transaction facts

Stored Form 4 columns with their raw values

Derivative
Type
unknown
Code C
Identifier
0002154030-26-000007
Convertible Promissory Notes
Transaction date
Oct 16, 2026
Filed Oct 19, 2026, 11:53 PM · 3d delay
Shares
742,546 sh
$0.00 per share
Estimated value
$0
Computed from shares × price
Holdings after
0 sh
Indirect · See footnote

Filing signal explanations

Badges describe filing facts only — not predictions.

Cluster 14dRepeat 30dPattern $100kLarge $1.00M
Derivative Transaction
Filing-only score

-16 points

Compact filing score computed from stored Form 4 facts. Version v1.

Mixed or weak signal

This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.

How this score is calculated
  • derivative_transaction-16 points

    is_derivative = true

    Derivative exercise rows are less discretionary than open-market purchases.
Read the scoring methodology

Signed filing-only points, not a probability or expected return. Version v1.

Reported relationships & other filings

Form 4 relationship flags and nearby filing context

Reported roles

No officer title

Officer NoDirector Yes10% NoOther No
Footnotes & amended
  1. F1

    Each share of Series A Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common…

  2. F2

    Each share of Series B Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Common…

  3. F3

    Each share of Series B-3 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Comm…

  4. F4F6F8(3 footnotes)

    The shares are held of record by Catalio Nexus Fund III, LP, or Catalio Nexus. Catalio Capital Management, LP, or Catalio Capital Mgmt, a registered investment advisor, is the investment manager for C…

  5. F5

    Each share of Series B-4 Convertible Preferred Stock automatically converted into Common Stock on a one-to-one basis immediately prior to the completion of the Issuer's initial public offering of Comm…

  6. F7

    The conversion price was equal to 85% of the Issuer's initial public offering price of $16.00 per share (reflecting a 15% discount).

Original filing · 0002154030-26-000007
Related transactions

0 other transactions

Same SEC filing
Recent company activity

0 recent txs

IAM